Status:

WITHDRAWN

Hospice Quality Score Assessment Post Pharmacist Intervention

Lead Sponsor:

Tabula Rasa HealthCare

Conditions:

Respiratory Disease

Cardiovascular Diseases

Eligibility:

All Genders

18-88 years

Brief Summary

The study aims to investigate the impact of pharmacist delivered interventions on hospice patients quality metric scores.

Detailed Description

The objective of this study is evaluate a program at a hospice involving activities designed to improve the site's National Quality Forum (NQF) and Consumer Assessment of Healthcare Providers and Syst...

Eligibility Criteria

Inclusion

  • Adult patients who were referred to hospice by a healthcare provider

Exclusion

  • Patients 89 years or older

Key Trial Info

Start Date :

April 22 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2022

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04361669

Start Date

April 22 2020

End Date

September 1 2022

Last Update

September 7 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Tabula Rasa HealthCare

Tucson, Arizona, United States, 85701

Hospice Quality Score Assessment Post Pharmacist Intervention | DecenTrialz